CV Reps Need to start selling something?

[Anonymous]

When is the upper management going to wake up and realize that CV Reps are sitting on their a--- doing nothing? It's time for them to start working for their pay and sell Onglyza & Kombi till we know more on Apixiban!

 

[Anonymous]

When is the upper management going to wake up and realize that CV Reps are sitting on their a--- doing nothing? It's time for them to start working for their pay and sell Onglyza & Kombi till we know more on Apixiban!

While it is true that many CV reps may be bored there are also many who are learning the hospitals, customers and territory and are grateful that they have the time to get some relationships.

 

[Anonymous]

Funny cause Diabetes reps are doing the same and selling a product on a daily basis....crazy huh? LOL

 

[Anonymous]

Shut the help up!! Learning hospitals were you hired with no experience? Again shut the hell up there's no need to kiss ass on the board. I bet the people in your distinct hate you.

 

[Anonymous]

While it is true that many CV reps may be bored there are also many who are learning the hospitals, customers and territory and are grateful that they have the time to get some relationships.

Amazing isn't it? They roll out a tertiary, me too, product in antipation of the release of a potential blockbuster, first in class, product, they re-adjust the salesforce to create two, distinct, disease state, teams to handle the fore mentioned diabetes blockbuster and a second one for the new cv team, there are a few bumps in the fda approval road and everyone is pointing fingers at everybody else? You can't sell. You aren't working. You people keep concentrating on what is NOT important and you will miss what is! CV team, when it is time, you will not get a year to place your product. You had better know who you have to blow to get that product to first in class within 6 months of release because your ass and your company is depending on it. Diabetes team, you should be doing everything to encourage them and to sell your product because without income, the company doesn't need any of you. Lastly, home office and sales management support team, before you point your finger of blame on the sales team ask yourself what you have done out of the ordinary to move forward. Remember when you point your finger, your thumb points back at you!

 

[Anonymous]

DBM'S on the line as well. I think you can only place so many reps on pip's before you should be placed on one. What about new hires? Hope they are going to sell something.

 

[Anonymous]

CV Reps Need to start selling something?

Why start now.

Never had to before.

For years, Stenting drove all the Plavix business and dropping samples got them in the office to check boxes on calls.

The goal was to find a new product with the same sort of profile. It worked before no need to fix what isn't broken.

 

[Anonymous]

CV Reps Need to start selling something?

Why start now.

Never had to before.

For years, Stenting drove all the Plavix business and dropping samples got them in the office to check boxes on calls.

The goal was to find a new product with the same sort of profile. It worked before no need to fix what isn't broken.

I successfully launched Capoten for CHF, Azactam IV for gram negative infections, Pravachol for hyperlipidemia, Glucophage, Glucophage XR, Avapro and Plavix. There were a few duds like Metaglip and Pravaguard. Each and every one of these products had to be sold to get it moving, including Plavix for ACS. I'm not saying there is not stenting business with Plavix, but there was always a reluctance to change from the medical community that had to be overcome. What is the difference between then and now? MHC formulary pushback and zero district level responsibilty to get it moving! That is what the RBD and DBMs should be doing, and if the Managed Care Representatives don't facilitate it like they didn't with Onglyza, they should be fired too!! I was.

 

[Anonymous]

CV Reps Need to start selling something?

Why start now.

Never had to before.

For years, Stenting drove all the Plavix business and dropping samples got them in the office to check boxes on calls.

The goal was to find a new product with the same sort of profile. It worked before no need to fix what isn't broken.

What about the suck Onglyza launch and sales? Oh that's right, that was marketings fault, not the lame diabetes "specialists". You're a fucking joke.

 

[Anonymous]

What about the suck Onglyza launch and sales? Oh that's right, that was marketings fault, not the lame diabetes "specialists". You're a fucking joke.

Honestly, without the advent of the STENT, Plavix would have been a billion, not 8 billion dollar drug.

 

[Anonymous]

Ok get over it. Plavix goes generic and apixaban is delayed. What do we sell??? Oh yeah branded Plavix. I guess now we will really have to start selling Haaaahaaa.

 

[Anonymous]

Amazing isn't it? They roll out a tertiary, me too, product in antipation of the release of a potential blockbuster, first in class, product, they re-adjust the salesforce to create two, distinct, disease state, teams to handle the fore mentioned diabetes blockbuster and a second one for the new cv team, there are a few bumps in the fda approval road and everyone is pointing fingers at everybody else? You can't sell. You aren't working. You people keep concentrating on what is NOT important and you will miss what is! CV team, when it is time, you will not get a year to place your product. You had better know who you have to blow to get that product to first in class within 6 months of release because your ass and your company is depending on it. Diabetes team, you should be doing everything to encourage them and to sell your product because without income, the company doesn't need any of you. Lastly, home office and sales management support team, before you point your finger of blame on the sales team ask yourself what you have done out of the ordinary to move forward. Remember when you point your finger, your thumb points back at you!

Very well said!!! It seems like home office only knows how to make short term plans. When those plan fails, they start scrambling and recreating and renaming strategies, e.g. MD Segmentation . . . what a joke!!!! like we haven't been doing this! Yes, this will make the difference . . .

 

[Anonymous]

I successfully launched Capoten for CHF, Azactam IV for gram negative infections, Pravachol for hyperlipidemia, Glucophage, Glucophage XR, Avapro and Plavix. There were a few duds like Metaglip and Pravaguard. Each and every one of these products had to be sold to get it moving, including Plavix for ACS. I'm not saying there is not stenting business with Plavix, but there was always a reluctance to change from the medical community that had to be overcome. What is the difference between then and now? MHC formulary pushback and zero district level responsibilty to get it moving! That is what the RBD and DBMs should be doing, and if the Managed Care Representatives don't facilitate it like they didn't with Onglyza, they should be fired too!! I was.

Managed Care people don't have a clue . . . it's a miracle if they know what accounts they're responsible for. What do they do?? How much interaction do they have with health plans on a daily basis?

 

[Anonymous]

Managed Care people don't have a clue . . . it's a miracle if they know what accounts they're responsible for. What do they do?? How much interaction do they have with health plans on a daily basis?

That's my point, the company rests their future with this group. Whether they thought about it or not. What have they done differently than what they did with the last five launches? Time to shake things up rather than point the crooked finger of fate at the the same people all the time!

 

[Anonymous]

What about the suck Onglyza launch and sales? Oh that's right, that was marketings fault, not the lame diabetes "specialists". You're a fucking joke.

Remember, included in that launch were our fabulous CV Specialty reps. So don't put the blame at the feet of the Diabetes "specialists". For the sake of the company, I sure hope they do a better job in launching Apixiban with the Cards than they did Onglyza, with the Endos? If not, we are all in trouble?

 

[Anonymous]

Remember, included in that launch were our fabulous CV Specialty reps. So don't put the blame at the feet of the Diabetes "specialists". For the sake of the company, I sure hope they do a better job in launching Apixiban with the Cards than they did Onglyza, with the Endos? If not, we are all in trouble?

Thank you for pointing out the problem with the launch. Endocrinologist use was the goal rather than Endocrinologist support. Why would a tertiary, me too, product be initiated by Endocrinologists? When the patient is sent to the Endocrinologist it is typically as a last resort and usually to start proper insulin training. Marketing should have concentrated on educating the Endocrinologists to educate the PCs as to when to use it. Instead we had claymation and Anna. When that didn't work we used whiz bang charts and then lastly incite to enrage!

 

[Anonymous]

Honestly, without the advent of the STENT, Plavix would have been a billion, not 8 billion dollar drug.

Think of the ironies in these statements, "Plavix would have been a billion dollar drug". Gee, sounds like a winner to me! "without the advent of the STENT". Modern cardiac stenting wouldn't have been possible without Plavix! To lift a phrase, What is past is prologue. Everybody should be worrying about what they're doing to move forward from here!

 

[Anonymous]

Think of the ironies in these statements, "Plavix would have been a billion dollar drug". Gee, sounds like a winner to me! "without the advent of the STENT". Modern cardiac stenting wouldn't have been possible without Plavix! To lift a phrase, What is past is prologue. Everybody should be worrying about what they're doing to move forward from here!

The only way it would have been a billion dollar drug w/o stents is price increases. Offers nothing that aspirin could not do alone w/o stents according to docs

 

[Anonymous]

The only way it would have been a billion dollar drug w/o stents is price increases. Offers nothing that aspirin could not do alone w/o stents according to docs

At the risk of sounding like a parrot, 21% R.R.R., 2.1% absolute risk reduction on top of asprirn, beta blocker, ace inhibitor, heparin, etc. in reducing the risk of m.i., stroke and vascular death w or w/o stenting in acute coronary syndrome is a therapeutic advancement.
Stay on the B.I. site dumb ass!

 

[Anonymous]

Remember, included in that launch were our fabulous CV Specialty reps. So don't put the blame at the feet of the Diabetes "specialists". For the sake of the company, I sure hope they do a better job in launching Apixiban with the Cards than they did Onglyza, with the Endos? If not, we are all in trouble?

Be honest, you would take 4 months with no drug, 100% bonus payout. Big deal, when apixa comes and it will, expectations will be through the roof.